The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies

被引:17
|
作者
Hu, Delphine
Hook, Edward W., III
Goldie, Sue J.
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Initiat Global Hlth, Cambridge, MA 02138 USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
10.1097/01.olq.0000200577.46261.b0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective/Goal: To understand the potential impact of assumptions about the natural history of untreated Chlamydia trachomatis on the cost-effectiveness of screening strategies. Study Design: Using a previously developed state-transition model, we explored how alternative assumptions about the natural history of disease following infection affect the estimated cost-effectiveness of screening for U.S. women. The analysis was conducted from a modified societal perspective and incorporated a lifetime analytic horizon. Results: Different natural history assumptions affect cost-effectiveness outcomes. Assumptions about the combined risk of persistent and repeat infections have the greatest impact on the composition of optimal screening strategies, whereas assumptions about the risk of pelvic inflammatory disease most greatly influenced the magnitude of incremental cost-effectiveness ratios. Conclusions: Priorities for future C trachomatis research should include better estimates of the risk of pelvic inflammatory disease, persistence, and repeat infection. Better delineation of these variables will permit improved evaluation of potential screening activities.
引用
收藏
页码:428 / 436
页数:9
相关论文
共 50 条
  • [41] Is screening for Chlamydia trachomatis infection cost effective?
    Paavonen, J
    GENITOURINARY MEDICINE, 1997, 73 (02): : 103 - 104
  • [42] ESTIMATING THE IMPACT AND COST-EFFECTIVENESS OF FULL IMPLEMENTATION OF SCREENING GUIDELINES FOR CHLAMYDIA AND GONORRHEA IN THE UNITED STATES
    Gift, Thomas
    Chesson, Harrell
    Maciosek, Michael
    SEXUALLY TRANSMITTED DISEASES, 2016, 43 : S127 - S128
  • [43] Women for Chlamydia trachomatis in family planning clinics - The cost-effectiveness of DNA amplification assays
    Howell, MR
    Quinn, TC
    Brathwaite, W
    Gaydos, CA
    SEXUALLY TRANSMITTED DISEASES, 1998, 25 (02) : 108 - 117
  • [44] COST-EFFECTIVENESS OF COMBINED TREATMENT FOR ENDOCERVICAL GONORRHEA - CONSIDERING COINFECTION WITH CHLAMYDIA-TRACHOMATIS
    WASHINGTON, AE
    BROWNER, WS
    KORENBROT, CC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (15): : 2056 - 2060
  • [45] COST-EFFECTIVENESS OF CULTURE AND DIRECT ANTIGEN TESTING FOR CHLAMYDIA TRACHOMATIS IN 2 THEORETICAL POPULATIONS
    NETTLEMAN, MD
    JONES, RB
    CLINICAL RESEARCH, 1986, 34 (04): : A912 - A912
  • [46] Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting
    Blake, Diane R.
    Maldeis, Nancy
    Barnes, Mathilda R.
    Hardick, Andrew
    Quinn, Thomas C.
    Gaydos, Charlotte A.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (07) : 649 - 655
  • [47] Screening strategies for active tuberculosis: focus on cost-effectiveness
    Dobler, Claudia Caroline
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 335 - 347
  • [48] The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland
    Pelczarska, Aleksandra
    Jakubczyk, Michal
    Jakubiak-Lasocka, Joanna
    Banach, Maciej
    Mysliwiec, Malgorzata
    Gruchala, Marcin
    Niewada, Maciej
    ATHEROSCLEROSIS, 2018, 270 : 132 - 138
  • [49] Cost-effectiveness of prenatal HIV screening strategies in Uganda
    Kim, Lena
    Vogel, Sinae
    Cohan, Deborah
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S236 - S236
  • [50] The cost-effectiveness of osteoporosis screening strategies for postmenopausal women
    Nayak, S.
    Greenspan, S. L.
    Liu, H.
    Michaud, K.
    Owens, D. K.
    Roberts, M. S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 410 - 411